AngioDynamics, Inc. (ANGO) Expected to Announce Earnings of $0.16 Per Share
Equities research analysts forecast that AngioDynamics, Inc. (NASDAQ:ANGO) will post $0.16 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for AngioDynamics’ earnings. The highest EPS estimate is $0.16 and the lowest is $0.15. AngioDynamics reported earnings of $0.19 per share in the same quarter last year, which would indicate a negative year over year growth rate of 15.8%. The business is expected to report its next quarterly earnings results before the market opens on Tuesday, July 18th.
According to Zacks, analysts expect that AngioDynamics will report full-year earnings of $0.70 per share for the current year, with EPS estimates ranging from $0.69 to $0.70. For the next year, analysts expect that the company will post earnings of $0.68 per share, with EPS estimates ranging from $0.66 to $0.70. Zacks’ EPS averages are an average based on a survey of research firms that cover AngioDynamics.
A number of research firms have recently issued reports on ANGO. Craig Hallum set a $20.00 price objective on AngioDynamics and gave the stock a “buy” rating in a report on Saturday, April 1st. Cantor Fitzgerald upped their price objective on AngioDynamics from $20.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, July 4th. Canaccord Genuity reiterated a “hold” rating and issued a $17.50 price objective on shares of AngioDynamics in a report on Thursday, March 30th. Finally, Zacks Investment Research upgraded AngioDynamics from a “hold” rating to a “buy” rating and set a $19.00 price objective for the company in a report on Wednesday, March 29th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. AngioDynamics presently has a consensus rating of “Buy” and an average target price of $18.58.
In related news, major shareholder Avista Capital Partners Gp, Ll sold 2,350,000 shares of the stock in a transaction dated Wednesday, April 12th. The stock was sold at an average price of $16.00, for a total transaction of $37,600,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.88% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Teachers Retirement System of The State of Kentucky raised its position in AngioDynamics by 77.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 7,100 shares of the medical instruments supplier’s stock worth $123,000 after buying an additional 3,100 shares during the last quarter. Municipal Employees Retirement System of Michigan raised its position in AngioDynamics by 3.0% in the first quarter. Municipal Employees Retirement System of Michigan now owns 7,200 shares of the medical instruments supplier’s stock worth $125,000 after buying an additional 210 shares during the last quarter. Mason Street Advisors LLC raised its position in AngioDynamics by 8.5% in the first quarter. Mason Street Advisors LLC now owns 7,470 shares of the medical instruments supplier’s stock worth $130,000 after buying an additional 584 shares during the last quarter. Acrospire Investment Management LLC acquired a new position in AngioDynamics during the first quarter worth approximately $149,000. Finally, Old Mutual Global Investors UK Ltd. acquired a new position in AngioDynamics during the first quarter worth approximately $164,000. 84.20% of the stock is owned by institutional investors and hedge funds.
AngioDynamics (NASDAQ ANGO) traded up 1.45% during trading on Tuesday, reaching $16.08. The company’s stock had a trading volume of 161,283 shares. AngioDynamics has a 52-week low of $14.06 and a 52-week high of $18.18. The company’s market cap is $591.42 million. The stock has a 50-day moving average price of $15.77 and a 200 day moving average price of $16.32.
AngioDynamics Company Profile
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.